Atomo Diagnostics Ltd (AT1) - Total Liabilities
Based on the latest financial reports, Atomo Diagnostics Ltd (AT1) has total liabilities worth AU$2.84 Million AUD (≈ $2.01 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Atomo Diagnostics Ltd to assess how effectively this company generates cash.
Atomo Diagnostics Ltd - Total Liabilities Trend (2017–2025)
This chart illustrates how Atomo Diagnostics Ltd's total liabilities have evolved over time, based on quarterly financial data. See what is Atomo Diagnostics Ltd's book value for net asset value and shareholders' equity analysis.
Atomo Diagnostics Ltd Competitors by Total Liabilities
The table below lists competitors of Atomo Diagnostics Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vogiatzoglou Systems S.A
AT:VOSYS
|
Greece | €12.35 Million |
|
Ralco Corporation Bhd
KLSE:7498
|
Malaysia | RM33.58 Million |
|
Way 2 Vat Ltd
AU:W2V
|
Australia | AU$7.17 Million |
|
Bayhorse Silver Inc
V:BHS
|
Canada | CA$2.49 Million |
|
Immo-Zenobe Gramme SA
BR:ZEN
|
Belgium | €8.06 Million |
|
Hamelin Gold Ltd
AU:HMG
|
Australia | AU$458.38K |
|
Skillful Craftsman Education Tech
NASDAQ:EDTK
|
USA | $2.10 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Atomo Diagnostics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AT1 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Atomo Diagnostics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Atomo Diagnostics Ltd (2017–2025)
The table below shows the annual total liabilities of Atomo Diagnostics Ltd from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$2.30 Million ≈ $1.63 Million |
+77.81% |
| 2024-06-30 | AU$1.29 Million ≈ $915.87K |
-23.11% |
| 2023-06-30 | AU$1.68 Million ≈ $1.19 Million |
-6.90% |
| 2022-06-30 | AU$1.81 Million ≈ $1.28 Million |
-15.96% |
| 2021-06-30 | AU$2.15 Million ≈ $1.52 Million |
+32.80% |
| 2020-06-30 | AU$1.62 Million ≈ $1.15 Million |
-85.94% |
| 2019-06-30 | AU$11.52 Million ≈ $8.15 Million |
-8.88% |
| 2018-06-30 | AU$12.64 Million ≈ $8.95 Million |
+6.97% |
| 2017-06-30 | AU$11.82 Million ≈ $8.36 Million |
-- |
About Atomo Diagnostics Ltd
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.